The U.S. Food and Drug Administration (FDA) on Wednesday approved Guardant Health Inc.’s GH Guardant360 Liquid CDx test, ...

As targeted therapies have grown in importance for treating cancers, the ability to detect genetic mutations that tumors carry has as well. While this often involves performing tissue biopsies, there ...

Shares of Guardant Health (GH) traded higher on Wednesday after the U.S. Food and Drug Administration approved its blood-based cancer test, Guardant360 Liquid CDx. Designed to integrate genomic and ...

Routine screening is limited to only a few cancer types. New research indicates that routine liquid biopsy testing (multi-cancer early detection testing) could substantially reduce late-stage cancer ...

Embedded in a small translucent wafer measuring just under an inch a side, the spiraling coils—like neatly packed iPod earbuds—aren’t much to look at. But judging on appearance alone would sell short ...